Search
TEMOZOLOMIDE ZENITH 250 MG, Gélule
Details
| --- | Description |
|---|---|
| Pack | Boite de 5 |
| Strength (Dosage) | 250 MG |
| Laboratory | ZENITH PHARMA |
| Ingredients | Temozolomide |
| Therapeutic class | Cytostatique alkylant |
| ATC code | L01AX03 |
| PPH | $308.30 |
| PPV | $339.50 |
| Refundable | Yes |
| Refund base | $339.50 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Not specified |
| Uses | Temozolomide est indiqué dans le traitement: des glioblastomes multiformes nouvellement diagnostiqués, en association avec la radiothérapie puis, comme traitement d'entretien des gliomes malins récidivants, comme les glioblastomes multiformes et les astrocytomes anaplasiques. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem